Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2014 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Non-Current Deferred Tax Liability of $249.9 million in Q1 2026, up 2.38% quarter-over-quarter from $244.1 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Non-Current Deferred Tax Liability history runs 13 years deep, the most recent figure standing at $249.9 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (changed N/A YoY), while the FY2025 annual figure was $244.1 million, down 30.75% from the prior year.
- Non-Current Deferred Tax Liability was $249.9 million for Q1 2026 at Zimmer Biomet Holdings, up from $244.1 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $541.3 million in Q3 2022 to a low of $244.1 million in Q4 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $419.3 million across 5 years, with a median of $470.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability tumbled 35.99% in 2022, then retreated 1.12% in 2023.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $474.8 million in 2022, then retreated by 24.68% to $357.6 million in 2023, then dropped by 1.43% to $352.5 million in 2024, then slumped by 30.75% to $244.1 million in 2025, then climbed by 2.38% to $249.9 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $249.9 million (Q1 2026), $244.1 million (Q4 2025), and $352.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.90 Mn |
| Mar 31, 2026 | 249.90 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Dec 31, 2022 | 474.80 Mn |
| Dec 31, 2022 | 474.80 Mn |
| Sep 30, 2022 | 541.30 Mn |
| Sep 30, 2022 | 541.30 Mn |